1  

 CURRICULUM VITAE

DATE: January 2018

NAME: Jeffrey L. Carson, M.D.

PRESENT TITLE: Provost-New Brunswick, Rutgers Biomedical Health Sciences Distinguished Professor, Department of Medicine, Rutgers, Robert Wood Johnson Medical School

Richard C. Reynolds, M.D. Chair in General Internal Medicine Vice Chair for Research, Department of Medicine,

Rutgers, Robert Wood Johnson Medical School CITIZENSHIP: USA EDUCATION:

A. Undergraduate Graduate and Professional University of Rhode Island Kingston, RI B. A. (Political Science) June 1973

 B. Graduate and Professional

Hahnemann Medical College Philadelphia, PA M.D. June 1977

 POSTGRADUATE TRAINING:

A. Internship and Residencies Hahnemann Medical College Philadelphia, PA Internship & Residency - July 1977 to June 1979 Chief Medical Resident – July 1979 to June 1980

 

B. Research Fellowships Hospital of the University of Pennsylvania Philadelphia, PA Henry J. Kaiser Family Foundation Fellowship in General Internal Medicine July 1980 to June 1982

 MILITARY: N/A

 ACADEMIC APPOINTMENTS:

Department of Medicine UMDNJ – Robert Wood Johnson Medical School Assistant Professor of Medicine July 1982 – June 1987 Department of Medicine University of Pennsylvania Adjunct Assistant Professor of Medicine July 1983 – June 1988

2  

Department of Medicine UMDNJ – Robert Wood Johnson Medical School Associate Professor of Medicine July 1987 – June 1994

Department of Medicine Rutgers – Robert Wood Johnson Medical School (formerly UMDNJ) Chief, Division of General Internal Medicine July 1987 – September 2015

Department of Medicine University of Pennsylvania Adjunct Associate Professor of Medicine July 1988 – June 1996 Department of Medicine Rutgers – Robert Wood Johnson Medical School (formerly UMDNJ) Professor of Medicine July 1994 - Present

Department of Medicine Rutgers – Robert Wood Johnson Medical School (formerly UMDNJ) Richard C. Reynolds, M.D. Chair in General Internal Medicine July 1996 – Present

Department of Medicine Rutgers – Robert Wood Johnson Medical School (formerly UMDNJ) Vice Chair for Research July 2012 – Present Interim Provost- New Brunswick Rutgers Biomedical and Health Sciences January 2014 – July 2014 Provost- New Brunswick Rutgers Biomedical and Health Sciences July 2014 – Present

HOSPITAL APPOINTMENTS:

Department of Medicine Cooper University Medical Center, Camden, NJ Attending July 1982 to June 1987

Department of Medicine Cooper University Medical Center, Camden, NJ Acting Head, Division of Internal Medicine July 1985 to June 1987

3  

Department of Medicine Robert Wood Johnson University Hospital, New Brunswick, NJ Attending July 1987 - Present

Center for Innovations in Bloodless Surgery & Medicine Robert Wood Johnson University Hospital Medical Director July 2000 to Present

Executive Health Program Robert Wood Johnson University Hospital Director July 2001 to June 2012

OTHER EMPLOYMENT OR MAJOR VISITING APPOINTMENTS: Fogarty Senior International Fellowship National Institutes of Health at University of Oxford Oxford, England 1995 - 1996

 PRIVATE PRACTICE : N/A LICENSURE: New Jersey #40558 Expiration 6/30/2019

 DRUG LICENSURE:

CDS: Expiration: 10/31/2017 DEA: Expiration: 8/31/2019

 CERTIFICATION: American Board of Internal Medicine – 1980 (no expiration)

 MEMBERSHIPS, OFFICES AND COMMITTEE ASSIGNMENTS IN PROFESSIONAL SOCIETIES:

American College of Physicians Fellow 1991 –

HONORS AND AWARDS: Phi Kappa Phi University of Rhode Island 1973 Golden Apple Award Rutgers Medical School at Camden 1985 and 1986 Special Student Teaching Award Rutgers Medical School at Camden 1987 Top Doctors List Castle Connolly 1998, 1999, 2000, 2001, 2002, 2003, 2004, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013,2014, 2015, 2017

4  

Residents Teaching Award UMDNJ- Robert Wood Johnson Medical School 1999 Faculty Recognition Award UMDNJ- Robert Wood Johnson Medical School Alpha Omega Alpha Medical Honor Society 2002 Edward J. Ill Excellence in Medicine Award: Outstanding Medial Research Scientist Award for Clinical Research UMDNJ- Robert Wood Johnson Medical School 2012

Excellence in Research Award Foundation of UMDNJ 2012 Research Mentorship Award Rutgers- Robert Wood Johnson Medical School Internal Medicine Residency Program 2012, 2014 Margot S. Kruskall Lectureship Harvard Medical School 2012 FOCUS Trial: Recognition as one of the 34 key research findings published in 2012 National Heart Lung Blood Institute 2012 Association of American Physicians (AAP) 2016

                                   Best Doctors in America List 2017-2018  

BOARDS OF DIRECTORS/TRUSTEES POSITIONS: N/A SERVICE ON NATIONAL GRANT REVIEW PANELS, STUDY SECTIONS, COMMITTEES: American Board of Internal Medicine Consultant – Computerized Base Examination Program, 1982 – 1984 National Board of Medical Examiners Consultant – Clinical Judgment Analysis Task Development Team 1986-1987 American College of Physicians Consultant- Clinical Privileges Project-Nephrology Subcommittee 1986-1987 National Institutes of Health Special Reviewer, Epidemiology & Disease Control Study Section I, 1987-1990 Member, Epidemiology & Disease Control Study Section I, 1990-1994 Reviewers Reserve, 1994 – 1998 Chair, Data Safety Monitoring Board

- Strategy to Reduce the Incidence of Postoperative Delirium in Elderly Patients (STRIDE), 2011 –

Member, Data Safety Monitoring Board - Age of Blood in the Pediatric Intensive Care Unit (ABC-PICU) 2013- - Partnership for Anemia: Clinical & Translational Trials in Elderly

5  

(Funded by National Institute of Aging) 2010 – Member- National Heart, Lung, Blood Institute, Clinical Trials Review Committee, 2010-2014 Chair- National Heart, Lung, Blood Institute, Clinical Trials Review Committee, 2014-2015

SERVICE ON MAJOR COMMITTEES: A. International (Name, Inclusive Dates)

REDS III – International Advisory Committee 2012- Canadian Institutes of Health Research – Chair, Data Safety Monitoring Board Transfusion in Cardiac Surgery (TRICS III) 2013-

B. National Society of General Internal Medicine

- Co-chair, Annual National Meeting 1989 - Chair, Mid-Atlantic Region 1990-1991 - Member, Nominations Committee 1991 - Chair, Committee on Students 1993-1995

National Heart Lung & Blood Institute - Special Emphasis Panel for Transfusion Network 2002 - Chair, Surgery subcommittee for State of Science for Transfusion Medicine

2008-2009 - Chair, Data Safety Monitoring Board, Warfarin Adherence Trial 2009- - Member, RBC Working Group for State of Science for Transfusion

Medicine, NHLBI 2014-2015 - Member, Plasma Transfusion Therapy Working Group for State of Science

for Transfusion Medicine, NHLBI 2014-2015

AABB (American Association of Blood Banks) - Member, Clinical Transfusion Medicine Committee 2005-2011 - Member, Plasma Transfusion Guidelines Committee 2009-2010 - Chair, Red Blood Cell Transfusion Guidelines Committee 2010-20122

Joint Commission National Summit on Overuse: Transfusion - Advisory Panel Member 2012

C. Medical School/University

UMDNJ – Cooper University Medical School at Camden Chairman, Curriculum Committee – Dept. of Medicine 1982-1987 Member, Residency Committee – Dept. of Medicine 1982-1987 Member, Academic Standing Committee 1983-1987 Member, Research Committee 1984-1987 Chairman, Medical Records Committee 1985-1987 UMDNJ – Rutgers Medical School Member, General Internal Medicine Task Force 1984-1985 Co-Chair, Joint Curriculum Task Force Committee 1985-1987 UMDNJ – Robert Wood Johnson Medical School Chairman, Educational Core, Dept. of Medicine 1987 – 1992 Member, Career Development Committee, Dept. of Medicine 1990-1999, 2010 - Chairman, Research in the Clinical Departments 1992 – 1994 Member, Research Committee 1993-1996, 2012 - Member, School-wide Appointment & Promotions Committee 1996-2006 Chair, Dept. of Medicine Resident Research Committee 2011 – Robert Wood Johnson University Medical Group Executive Council 2010 –

Rutgers University, Institute for Health, Health Care Policy, & Aging Research Associate Member 1990

6  

University of Pennsylvania, Hematology K12 External Advisory Board 2010- D. Hospital Robert Wood Johnson Foundation Network on Health Care Costs 2012- E. Department (Name, Inclusive Dates) F. Editorial Boards (Journal Name, Inclusive Dates) G. AdHoc Reviewer

Agency for Health Care Policy and Research 1990

SERVICE TO THE COMMUNITY:

Health Wellness Promotion Advisory Board of New Jersey 1996 – 1999 New Jersey Public Health Council 2004-2005

 SPONSORSHIP (Primary Mentorship) OF CANDIDATES FOR POSTGRADUATE DEGREE:

SPONSORSHIP (Primary Mentorship) OF POSTDOCTORAL FELLOWS:

TEACHING RESPONSIBILITIES: A. Lectures or Course Directorships

Resident Journal Club- Weekly 1 hour  

B. Research Training (other than Primary Mentorship) None

 

CLINICAL RESPONSIBILITIES: Internal Medicine Teaching Service 1-2 months per year General Internal Medicine Consult Service 1-2 months per year Outpatient General Internal Medicine Practice 2- ½ days per week Executive Health ½ day per week 2001-2012

 GRANT SUPPORT:

A. Principal Investigator 1. NIH; Anemia and Surgery: Indications for Transfusion. 4/1990 to 3/1995 349,952 2. National Blood Foundation; Cost-Effectiveness of Autologous Transfusion. 4/1993 to 9/1995 $29,886 3. Agency for Health Care Policy and Research; Surgical Blood Transfusion: Variation and Outcome. 4/1993 to 5/1996 $3,009,070 4. Ortho Biotech; The Risk of Bacterial Infection after Allogeneic Transfusion. 7/1995 to 13/1996 $104,848 5. Fogarty International Center NIH; Senior International Fellowship 9/1995 to 6/1996 $31,484 6. Northfield Laboratories; Outcomes of Surgical Patients with Very Low Blood Counts. 11/1999 to 4/2000 $18,855 7. National Blood Foundation and Ortho Biotech; The Effect of Anemia and Transfusion on Postoperative Delirium. 7/2000 to 6/2001 $52,710 8. Amgen Inc.; Trial to Evaluate the Effect of Darbepoetin alfa on Transfusion and

7  

Functional Recovery in Elderly Hip Fracture Patients. 7/2002 to 6/2004 $369,999 9. NIH; Transfusion Therapy Trial for Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair (FOCUS). 9/2003 to 8/2012 $8,156,115 10. NIH; FOCUS Administrative Supplement. 9/2005 to 8/2011 $109,147 11. NIH; FOCUS: Detection of Myocardial Infarction. 9/2005 to 8/2011 $2,220,571 12. NIH; Transfusion Trigger Trial in Coronary Artery Disease: A Pilot Study. 9/2009 to 8/2012 $2,605,143 13. NIH; FOCUS Administrative Supplement. 2/2010 to 8/2012 $145,763 14. NIH; FOCUS Administrative Supplement. 5/2011 to 8/2012 $151,532 15. NIH/RTI International; Recipient Epidemiology and Donor Evaluation Study III- Data Coordinating Center. 3/2012 to 3/2017 $112,137 16. NIH; Does Plasma Reduce Bleeding in Patients Undergoing Invasive Procedures. 9/2015-8/2017 $ 740,535 17. NIH: MINT: Myocardial infarction and transfusion. 9/2016 to 8/ 2021. $10.3 million, 16.1 million total

B. Co-Investigator 1. Agency for Health Care Policy and Research; Risk and Risk Factor Modeling. 2/1992 to 1/1996. $22,600 PI: Louise Russell

2. Agency for Health Care Policy and Research; Surgical Blood Transfusion: Variation and Outcome. 4/1993 to 9/1995 $767,906 PI: Mark Taragin, MD

3. Ortho Biotech; Cost of Bacterial Infections After Allogeneic Blood Transfusion. 7/1995 to 12/1996 $104,848 PI: Frank Sonnenberg, MD 4. UMDNJ Foundation; Cardiology Consultation to Generalist Physicians’ Elderly Patients with Heart Attack: Prevalence and Impact on Survival. 7/1997 to 6/1998 $25,000 PI: Arnold Chen, MD 5. NIH; PSA Screening and Prostate Cancer Mortality. 1/1997 to 6/2001 $260,644 PI: George Rhoads 6. University of Maryland Subcontract/NIH; FOCUS: Ancillary study on Delirium 12/2008 to 1/2012 $198,737 PI: Ann Gruber-Baldini, PhD 7. NIH; Red Cell Storage Duration Study. 10/2009 to 9/2014 $5,663/pt randomized PI: S. Assmann 8. NIH; Recipient Epidemiology and Donor Evaluation Study III (REDS III). 3/2012 to 2/2018 $318,458 PI: H. Shan 9. NIH; Mechanism and Repository Study (MARS) Substudy. 5/2013 to 9/2014 $4,640/pt randomized PI: S. Assmann 10. McMaster University; Manage Trial. 12/2013 to 12/2016. $ 5,950/pt randomized

PI: P.J. Deveaueux 11. University of Pennsylvania: REGAIN trial. 11/2015 to 10/ 2020. 15% time

C. Pending   

PUBLICATIONS:  

A. Refereed Original Article in Journal 1. Carson JL, Schwartz JS (Health and Public Policy Committee for the American College of Physicians):

Implantable and external infusion Pumps for the treatment of thromboembolic disease in outpatients. Annals Internal Medicine 1984; 100: 305-6.

2. Carson JL, Strom BL, Morse ML: The COMPASS Data Base - An Epidemiologist Viewpoint. Proceedings of the Drug Information Association 1984. 20th Annual Meeting Worldwide Drug Development and Scientific Data Management, 1984.

3. Carson JL, Eisenberg JM, Shaw L, Soper K, Kundel H: Comparison of the diagnostic accuracy of four assays of prostatic acid phosphatase using ROC curve analysis. JAMA 1985; 253: 665-9.

4. Strom BL, Carson JL, Morse ML, Leroy AA. The Computerized On-Line Medicaid Pharmaceutical Analysis and Surveillance System. A new resource for post-marketing drug surveillance. Clinical

8  

Pharmacology and Therapeutics 1985; 38: 359-64. 5. Carson JL, Strom BL, Soper KA, West SL, Morse ML. The association of nonsteroidal

anti-inflammatory drugs with upper GI bleeding. Archives Internal Medicine 1987; 147:85-8. 6. Strom BL, Carson JL, Shinnar R, Sim E, Maislin G, Soper K, Morse ML: Comparative risk of upper

gastrointestinal bleeding from oral potassium chloride in a microencapsulated versus a wax-matrix formulation. Archives Internal Medicine l987; l47: 954-7.

7. Carson JL, Strom BL, Morse ML, West SL, Soper KA, Stolley SL, Soper KA, Stolley PD, Jones JR:The Relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs. Archives Internal Medicine 1987; 147: 1054-9.

8. Strom BL, Carson JL, Morse ML, West SL, Soper KA: Allergic and/or anaphylactoid reactions associated with zomepirac sodium and other non-steroidal anti-inflammatory drugs. Arthritis and Rheumatism. l987; 30: 1142-8.

9. Carson JL (Committee on Clinical Privileges, Subcommittee on Nephrology for the American College of Physicians). Clinical competence in percutaneous renal biopsy. Annals Internal Medicine 1988; 108:301-3.

10. Carson JL (Committee on Clinical Privileges, Subcommittee on Nephrology for the American College of Physicians). Clinical competence in acute hemodialysis. Annals Internal Medicine 1988; 108: 632-4.

11. Carson JL (Committee on Clinical Privileges, Subcommittee on Nephrology for the American College of Physicians). Clini12. Carson JL, Poses RM, Spence RK, Bonavita G: Severity of anemia and operative mortality and

morbidity. Lancet. 1988;1:727-29. 13. Carson JL (Committee on Clinical Privileges, Subcommittee on Nephrology for the American College of

Physicians). Clinical competence in continuous arteriovenous hemofiltration. Annals Internal Medicine 1988; 108:900-902.

14. Strom BL, Carson JL, Schinnar R, Sim E, Morse ML. The effect of the indication on the risk of hypersensitivity reactions associated with tolmetin sodium vs. other non-steroidal anti-inflammatory drugs. Journal of Rheumatology 1988;15:695-699.

15. Carson, JL. Nonsteroidal anti-inflammatory drugs and serious GI toxicity. Orthopedic Audio-Synopsis Foundation 1988:20(2).

16. Carson JL. A Case Study; Nonsteroidal antiinflammatory drugs and gastrointestinal bleeding. Journal of Rheumatology 1988; (Suppl 17) 15:24-27.

17. Strom BL, Carson JL. Automated databases used for Pharmacoepidemiology research. Clinical Pharmacology and Therapeutics. 1989;46:390-4.

18. Strom BL, West SL, Sim D, Carson, JL. The epidemiology of the acute flank pain syndrome from suprofen. Clinical Pharmacology and Therapeutics. 1989;46:693-9.

19. Strom, BL, Carson, JL, Schinnar R, Snyder ES, West S. Hypersensitivity reactions from zomepirac and other nonsteroidal anti-inflammatory drugs. Epidemiologie Clinique. 1989:2:77-90.

20. Spence RK, Carson JL, Poses R, McCoy S, Pello M, Alexander J, Popovich J, Norcross E, Camishion RC. Elective surgery without transfusion: Influence of preoperative hemoglobin level and blood loss on mortality; American Journal Surgery 1990;159:320-324.

21. PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results from the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 1990;263:2753-9.

22. Taragin MI, Carson JL, Strom BL. Gastrointestinal side effects of the nonsteroidal anti-inflammatory drugs Digestive Disease 1990;8:269-280.

23. Strom BL, Carson JL. Medicaid billing data used to study the effects of marketed drugs. Drug Information Journal 1990;24:477-483.

24. Kelly MA, Carson JL, Palevsky HI, Schwartz JS. Diagnosing pulmonary embolism: New facts and strategies. Annals of Internal Medicine 1991;114:300-306.

25. Strom BL, Carson JL, Halpern AC, Schinnar R, Snyder ES, Shaw M, Tilson HH, Joseph M, Dai WS, Chen D, Stern, RS, Bergman U, Stolley PD. Using a claims database to investigate drug-induced Stevens-Johnson syndrome. Statistics in Medicine 1991;10:565-576.

26. Trontell MC, Carson JL, Taragin MI, Duff A. The impact of the night float system on Internal Medicine residency programs; Journal of General Internal Medicine 1991;6:445-449.

27. Strom BL, Carson JL, Schinnar R, Snyder ES, Shaw M, Waiter, S. Pharmacoepidemiology and drug utilization - no causal relationship between transdermal scopolamine and seizures: Methodologic lessons for pharmacoepidemiology; Clinical Pharmacology and Therapeutics 1991;50:107-113.

9  

28. Strom BL, Carson JL, Halpern AC, Schinnar R, Snyder ES, Shaw M, Tilson HH, Joseph M, Dai WS, Chen D, Stern RS, Bergman U, Stolley PD. A population-based study of Stevens-Johnson syndrome: Incidence and antecedent drug exposures. Archives of Dermatology 1991;127:831-838.

29. Carson JL, Strom BL, Schinnar R, Duff A, Sim E. The low risk of upper gastrointestinal bleeding in patients dispensed corticosteroids. American Journal of Medicine 1991;91:223-228.

30. Carson JL, Russell LB, Taragin MI, Duff AE, Bauer S. The risks of blood transfusion: The relative influence of AIDS and non-A non-B hepatitis. American Journal of Medicine. 1992;92:45-52

31. Carson JL, Kelley ML, Terrin ML, Duff AE, et al. The clinical course of pulmonary embolism. New England Journal of Medicine 1992;326:1240-5.

32. Carson JL, Strom BL, Duff A, Gupta A, Das K. The feasibility of studying acute hepatitis using Medicaid data. Clinical Pharmacology and Therapeutics 1992;52:214-19.

33. Taragin MI, Willett LR, Wilczek AP, Trout R, Carson JL. The influence of standard of care and severity of injury on the resolution of medical malpractice. Annals of Internal Medicine 1992;117:780-4.

34. Taragin MI, Wilczek AP, Karns ME, Trout R, Carson JL. Physician demographics and the risk of medical malpractice. American Journal of Medicine 1992;93:537-542.

35. Strom BL, Carson JL, Schinnar R, Sims E, Shaw M. Descriptive epidemiology of agranulocytosis. Archives of Internal Medicine 1992;152:1475-80.

36. Carson JL, Strom BL, Duff A, Gupta A, Das K. Safety of NSAIDs with respect to acute liver disease. Archives of Internal Medicine 1993;153:1331-6.

37. Spence RK, Cernaianu AC, Carson JL, Delrossi AJ. Transfusion and surgery. Current Problems in Surgery 1993;12:1102-92.

38. Strom BL, Carson JL, Schinnar R, Sims E, Shaw M, Lundin FE. Nonsteroidal anti-inflammatory drugs and neutropenia. Archives of Internal Medicine 1993:153:2119-24.

39. Carson JL, Strom BL, Duff A, Gupta A, Shaw M, Lundin FE, Das K. Acute liver disease associated with erythromycins, sulfonamides, and tetracyclines. Annals of Internal Medicine 1993;119:576-583

40. Carson JL, Duff A, Strom BL. Drug induced hepatitis. Pharmacoepidemiology and Drug Saftey 1993;2:S19-S23.

41. Carson JL, Ruddy ME, Duff AE, Holmes NJ, Brolin RE. The effect of gastric bypass surgery on hypertension in morbidly obese patients. Archives of Internal Medicine 1994;154;193-200.

42. Grisso JA, Strom BL, Cosmatos I, Tolosa J, Main D, Carson JL. Diagnostic ultrasound in pregnancy and low birthweight. American Journal of Perinatology 1994;11;297-301.

43. Taragin MI, Sonnenberg FA, Wilczek AP, Karns ME, Trout R, Carson JL. Does physician performance explain inter-specialty differences in malpractice claims. Medical Care 1994;32:661-7.

44. Strom BL, Carson JL, Schinnar R, Shaw M. Is cimetidine associated with neutropenia. American Journal of Medicine 1995;99:282-290.

45. Taragin MI, Martin K, Shapiro S, Trout R, Carson JL. Physician malpractice: Does the past predict the future? Journal of General Internal Medicine 1995;10:550-556.

46. Strom BL, Berlin JA, Kinman JL, Spitz PW, Hennessy S, Feldman H, Kimmel S, Carson JL. Parenteral Ketorolac and risk of gastrointestinal and operative site bleeding: A post-marketing surveillance study. JAMA 1996;275:376-382.

47. Henry D, Lim LLY, Garica Rodriquez LA, Perez Gutthann S, Carson JL, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs. Results of a collaborative meta-analysis. BMJ 1996;312:1563-6.

48. Carson JL, Terrin ML, Duff A, Kelley MA. Pulmonary embolism and mortality in patients with chronic obstructive pulmonary disease. Chest 1996;110:1212-9.

49. Daly E, Vessey MP, Hawkins MM, Carson JL, Parimala G, Marsh S. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996;348:977-980.

50. Carson JL, Duff A, Poses RM, Berlin JA, Spence RK, Trout R, Noveck H, Strom BL. Effect of anemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996;348:1055-1060.

51. Feldman HI, Kinman JL, Berlin JA, Hennessy S, Kimmel SE, Farar J, Carson JL, Strom BL. Parenteral keterolac: The risk of acute renal failure. Ann Intern Med 1997;126:193-199.

52. Hennessy S, Kinman JL, Berlin JA, Feldman HI, Carson JL, Kimmel SE, Farrar J, Harb G, Strom BL. Lack of hepatotoxic effects of parenteral keotrolac in the hospital setting. Arch Intern Med 1997;157;2510-4.

53. Strom BL, Schinnar R, Bilker WB, Feldman H, Farrar JT, Carson JL. Gastrointestinal bleeding from

10  

Naproxen vs. Ibuprofen. Arch Intern Med 1997;157:2626-31. 54. Grisso JA, Carson JL, Feldman HI, Cosmatos I, Shaw M, Strom B. Epidemiological pitfalls using

Medicaid data in reproductive health research. J Maternal-Fetal Med 1997;6:230-6. 55. Levine SF, Carson JL. A logical approach to identifying pulmonary embolism. IM Internal Medicine

1998;19:38-46. 56. Miller JE, Russell LB, Davis DM, Milan E, Carson JL, Taylor WC. Biomedical risk factors for hospital

admission in older adults. Medical Care 1998;36:411-421. 57. Russell LB, Carson JL, Taylor, WC, Milan E, Dey A., Jagannathan, R. Modeling all-cause mortality:

Projections of the impact of smoking cessation based on the NHEFS. Am J Public Health, 1998;88:630-636.

58. Carson JL, Duff A, Berlin JA, Lawrence VA, Poses RM, Huber EC, O’Hara DA, Noveck H, Strom BL. Influence of perioperative blood transfusion on postoperative mortality. JAMA.1998;279:199-295.

59. Carson JL, Terrin ML, Barton FB, Aaron R, Greenburg AG, Heck DA, Magaziner J, Merlino FE, Bunce G, McClelland B, Duff A, Noveck H. et al. A randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell transfusion following hip fracture. Transfusion 1998;38:522-529.

60. Poses RM, Berlin JA, Noveck H, Lawrence VA, Huber EC, O’Hara DA, Spence RK, Duff A, Strom BL, Carson JL. How you look determines what you find: severity of illness and variation in blood transfusion for hip fracture. Am J Med. 1998;105:198-206.

61. Carson JL, Altman DG, Duff A, Noveck H, Weinstein MP, Sonnenberg FA, Hudson JI, Provenzano G. Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion 1999;39:694-700.

62. Sonnenberg FA, Gregory P, Yomtovian R, Russell L.B, Tierney W, Kosmin M, Carson JL. The cost-effectiveness of autologous transfusion revisited: implications of an increased risk of bacterial infection with allogeneic transfusion. Transfusion 1999;39:808-17.

63. O’Hara DA, Duff A, Berlin JA, Poses RM, Lawrence VA, Huber EC, Noveck H, Strom BL, Carson JL. The effect of anesthetic technique on postoperative outcomes in hip fracture repair. Anesthesiology 2000;92:947-57.

64. Kimmel SE, Berlin JA, Miles C, Jaskowiak J, Carson JL, Strom BL. Risk of acute first myocardial infarction and use of nicotine patches in a general population. J Am Coll Cardiol 2001;37:1297-302. 65. Sullivan-Marx EM, Kurlowicz LH, Maislin G, Carson JL. Physical restraint among hospitalized nursing

home residents: Predictors and outcomes. Clinical Gerontologist 2001;24:85-101. 66. Rosen RC, Zozula R, Jahn EG, Carson JL. Low rates of recognition of sleep disorders in primary care:

comparison of a community-based versus clinical academic setting. Sleep Medicine 2001; 2(1):47-55. 67. Kimmel,SE, Berlin JA, Kinman JL, Hennessy S, Feldman H, Carson JL, Strom BL. Parenteral keterolac

and risk of myocardial infarction. Pharmacoepidemiology and Drug Safety 2002;11:113-119. 68. Sauer WH, Berlin JA, Strom BL, Miles C, Carson JL, Kimmel SE. Cigarette yield and the risk of

myocardial infarction in smokers. Archives Internal Medicine 2002;162:300-306. 69. Grimes JP, Gregory P, Noveck H, Butler MS, Carson JL The influence of time-to-surgery on mortality

and morbidity in hip fracture patients. American Journal of Medicine 2002;112:702-709. 70. Carson JL, Noveck H, Berlin JA, Gould SA. Mortality and morbidity in patients with very low

postoperative hemoglobin levels who decline blood transfusion. Transfusion 2002;42:812-8. 71. Carson JL, Ferreira G. Response to questions: USA. Vox Sanguis 2002;82:218-220 72. Carson JL, Scholz P., Chen AY, Peterson ED, Gold J, Schneider SH. Diabetes mellitus increases short-

term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. Journal American College Cardiology 2002;40:418-23.

73. Palmer MH, Baumgarten M, Langenberg P, Carson JL. Risk factors for hospital acquired incontinence in elderly female hip fracture patients. Journal of Gerontology: Medical Sciences 2002;57:M672-M677.

74. Lawrence VA, Hilsenback SG, Noveck H, Poses RM, Carson JL. Medical complications and outcomes after hip fracture repair. Archives of Internal Medicine 2002;162:2053-2057.

75. Gould SA, Moore EE, Hoyt DB, Ness,PM, Norris,EJ, Carson JL Hides,GA, Freeman IH, DeWoskin R, Moss,GS. The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. Journal American College Surgery. 2002;195:445-452.

76. Baumgarten M, Margolis D, Berlin JA, Strom BL, Garino J, Kagan SH, Kavesh W, Carson JL. Risk factors for pressure ulcers among elderly hip fracture patients. Wound Repair Regen 2003;11(2):96-103.

77. Carson JL, Armas-Loughran B. Blood transfusion: less is more? Crit Care Med 2003;31:2409-2410.

11  

78. Marcella SW, Rhoads GG, Carson JL, Merlino F, Wilcox H. Prostate-specific antigen screening and mortality from prostate cancer. J Gen Intern Med 2008;23:248-53. 79. Steinberg MB, Greenhaus S, Schmelzer AC, Bover MT, Foulds J, Hoover DR, Carson JL. Triple-

combination pharmacotherapy for medically ill smokers: a randomized trial. Ann Intern Med 2009;150:447-454.

80. Tobian AR, Ness PM, Noveck H, Carson JL. Time course and etiology of death in patients with severe anemia . Transfusion 2009;49:1395-1399.. 81. Patel MS, Carson JL. Anemia in the preoperative patient. Anesthesiol Clin 2009;27:751-60. 82. Vogel TR, Dombrovskiy VY, Carson JL, Haser PB, Graham AM. Lower extremity angioplasty: Impact Of practitioner specialty and volume on practice patterns and healthcare resource utilization. J Vasc Surg 2009;50;1320-25. 83. Vogel TR, Dombrovskiy VY, Carson JL, Haser PB Graham AM, Lowry SF. Infectious complications after elective vascular surgical procedures. J Vascular Surgery 2010;51:122-130. 84. Vogel TR, Dombrovskiy VY, Carson JL, Graham AM, Lowry SF. Postoperative sepsis in the United States. Annals of Surgery 2010; 252;1065-1071. 85. Carson JL, Kim S. Intraoperative transfusion in older patients with low preoperative haematocrit levels and substantial blood loss during major non-cardiac surgery is associated with lower 30-day postoperative mortality. Evid Based Med 2010;15:185-6. 86. Carson JL. Transfusion triggers: state of the art in 2010. Acta Anaesthesiol Belg 2010;61:145. 87. Roback JD, Caldwell S, Carson JL, Davenport M, et al. Evidence-based practice guidelines for plasma transfusion.. Transfusion 2010;50: 1227-39. 88. Vogel TR, Dombrovskiy VY, Carson JL, Graham AM. In-hospital and 30-day outcomes after tibioperoneal interventions in the US Medicare population with critical limb ischemia. J Vasc Surg 2011;54:109-15. 89. Steinberg, MB, Randall J, Greenhaus S, Schmelzer C, Richardson DL, Carson JL. Tobacco dependence treatment for hospitalized smokers: a randomized, controlled, pilot trial using varenicline. Addictive Behaviors 2011;36:1127-32. 90. Carson JL, Terrin ML, Noveck H, Sanders DW, et al. Liberal or Restrictive Transfusion in High Risk Patients After Hip Surgery. N Engl J Med 2011; 365: 2453-62. 91. Willett, LR, Carson JL. Red blood cell transfusion in the elderly: the search for transfusion triggers. Aging Health 2012;8:387-392. 92. Carson JL, Carless PA, Hebert PC. Outcomes using Lower vs. Higher Hemoglobin Thresholds For Red Blood Cell Transfusion. JAMA 2013;309:83-84. 93. Carson JL Brooks MM, Abbott JD, Chaitman B, Kelsey SF, Triulzi DJ, Srinivas V, Menegus, MA, Marroquin OC, Rao SV, Noveck H, Passano E, Hardison RM, Smitherman T, Vaganescu T, Wimmer NJ, Williams DO. Liberal Versus Restrictive Transfusion Thresholds For Patients With Symptomatic Coronary Artery Disease. American Heart Journal 2013;165:964-971 94. Hogshire, L, Carson JL. Red Blood Cell Transfusion: What is the Evidence When to Transfuse? Current Opinion in Hematology 2013; 20:546-551. 95. Gruber-Baldini AL, Marcantonio E, Orwig D, Magaziner J, Terrin M, Barr E, Brown JP, Paris B, Zagorin A, Roffey DM, Zakriya K, Blute MR, Hebel, JR, Carson JL. Delirium outcomes in a randomized trial of blood transfusion thresholds in hospitalized older adults with hip fracture. Journal of the American Geriatrics Society 2013;61(8):1286-95. 96. Willett LR, Carson JL. Management of postoperative complications: anemia. Clinics in geriatric medicine

2014;30:279-84. 97. Roubinian NH, Escobar GJ, Liu V, Gardner, MN, Carson, JL, Kleinman, SH, Murphy, EL. Trends in red

blood cell transfusion and 30-day mortality among hospitalized patients. Transfusion 2014; 54:2678-86. 98. Roubinian NH, Escobar GJ, Liu V, Gardner, MN, Carson, JL, Kleinman, SH, Murphy, EL. Decreased red

blood cell use and mortality in hospitalized patients. JAMA internal medicine 2014;174:1405-7. 99. Carson JL, Sieber F, Cook DR, Hoover DR, Noveck H, Chaitman BR, Fleisher, L, Beaupre L, Macaulay

W, Rhoads GG, Paris B, Zagorin A, Sanders DW, Zakriya KJ, Magaziner J, Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomized controlled trial. Lancet 2015: 385:1183-9.

100. Steiner ME, Ness PM, Assmann SF, Triulzi, DJ, Sloan SR, Delaney M, Granger S, Bennett-Guerrero E, Blajchman MA, Scavo V, Carson JL , et al. Effects of red-cell storage duration on patients undergoing

12  

cardiac Surgery. N Engl J Med. 2015;372:1419-1429. 101. Albrecht JS, Marcantonio ER, Roffey DM, Orwig D, Magaziner, J, Terrin, M, Carson JL, Barr E, Brown J

P, Gentry E G, Gruber-Baldini A L. Stability of postoperative delirium psychomotor subtypes in individuals with hip fracture. J Am Geriatr Soc 2015;63:970-6.

102. Beaupre LA, Carson JL, Noveck H, Magaziner J. Recovery of Walking Ability and Return to Community Living within 60 Days of Hip Fracture Does Not Differ Between Male and Female Survivors. J Am Geriatr Soc 2015.

103. Holst LB, Carson JL, Perner A. Should red blood cell transfusion be individualized? No. Intensive Care Med 2015; 41: 1977-79

104. Roubinian NH, Carson JL. Restrictive red blood cell transfusion strategies appear safe in most clinical settings. Evid Based Med 2015. published on July 28, 2015 as 10.1136/ebmed-2015-110218

105. Carson, JL, Guyatt G, Heddle NM, Grossman BJ etal. Clinical Practice Guidelines from the: AABB*: Red Blood Cell Transfusion Thresholds and Storage. JAMA 2016;316:20125-2035 (on line October 12, 2016)

 

B. Books, Monographs and Chapters

1. Carson JL, Eisenberg JM: Preoperative Screening in Medical Care of the Surgical Patient, Goldman, D., et al (eds.), Lippincott, 1982.

2. Carson JL, Strom BL: Screening for Unknown Effects of Newly Market Drugs in Pharmacoepidemiology - The Science of Post-Marketing Drug Surveillance, Churchill Livingstone, Inc., New York, New York 1989; 289-306.

3. Carson JL, Strom BL, Morse ML: Medicaid Data Bases. Pharmocoepidemiology - The Science of Post-Marketing Drug Surveillance, Churchill Livingstone, Inc., New York, New York 1989; 173-188.

4. Carson JL: Early Experience with the COMPASS data base in Pharmocoepidemiology. ed Edlavitch SA. Lewis Volume 1 1989. p.211-216

5. Strom, BL, Carson JL. Nonsteroidal anti-inflammatory drugs and upper gastrointestinal bleeding Pharmocoepidemiology ed. Edlavitch SA. Lewis Volume 1 1989. p.229-242

6. Carson JL, Strom BL. The gastrointestinal toxicity of the non-steroidal anti-inflammatory drugs. Side-Effects of Anti-Inflammatory Drugs 3 eds. Rainsford KD, Velo GP. Kluwer Academic Publishers Volume 3 1992 p 1-8.

7. Strom BL, Carson JL, Schinnar R, Snyder ES, West S. Non-steroidal anti-inflammatory drugs and hypersensitivity reactions. Side-Effects of Anti-Inflammatory Drugs 3 ed. Rainsford KD, Velo GP. Kluwer Academic Publishers Volume 3 1992 p 22-26.

8. Carson JL, Strom BL. Screening for Unknown Effects of Newly Marketed Drugs: Strom BL, Velo G. Drug Epidemiology and Post-Marketing Drug Surveillance. Plenum Press Volume 224 p 73-82.

9. Carson JL, Eisenberg JM: Preoperative Screening in Perioperative Care., Goldman, D., et al (eds.), Lippincott, 1994:15-23.

10. Carson JL, Strom BL. Nonsteroidal antiinflammatory drugs in Principles of Geriatric Medicine and Gerontology. Hazzard WR, et al (eds), McGraw Hill, Third Edition 1994:947-53.

11. Carson JL, Strom BL, Maislin G: Screening for Unknown Effects of Newly Market Drugs. Pharmacoepidemiology - The Science of Post-Marketing Drug Surveillance, Strom BL (ed), Churchill

12. Livingstone, Inc., New York, New York 1994:431-47. 13. Carson JL, Strom BL. Medicaid Data Bases. Pharmocoepidemiology - The Science of Post-Marketing

Drug Surveillance, Strom BL (ed), Churchill Livingstone, Inc., New York, New York 1994:199-216. 14. Carson JL. Red blood cell transfusion in patients with cardiac and pulmonary disease. Clinical Practice of

Transfusion Medicine. Petz LD et al. (Eds), Churchill Livingstone, Inc., New York 1995 15. Carson JL. When should physicians transfuse? Manning FJ, Sparacinio L, eds. Blood Donors and the

Supply of Blood and Blood Products. Washington, D.C.: National Academy Press, 1996:19-24. 16. Carson JL. Nonsteroidal Anti-inflammatory drugs. Manual of Clinical Problems in Adult Ambulatory

Care. Dornbrand L, et al. (eds), Little Brown and Co 1997 17. Carson JL, Strom BL. Nonsteroidal antiinflammatory drugs. Principles of Geriatric Medicine and

13  

Gerontology. Hazzard WR, et al (eds), McGraw Hill, Fourth Edition 1999. 18. Carson JL, Ray W, Strom BL. Medicaid Data Bases. Pharmocoepidemiology - The Science of Post-

Marketing Drug Surveillance, Strom BL (ed), Churchill Livingstone, Inc., New York, New York 2000. 19. Levine SF, Carson JL. Pulmonary embolism. Hospital Medicine. Wachter RM, Goldman L, Hollander H,

(Eds), Williams and Wilkins, Baltimore. 2000 20. Carson JL, Hébert P. Anemia and Red Blood Cell Transfusion. Ross’s Principles of Transfusion

Medicine. Simon TL, Dzik WH, Snyder E, Stowell CP, Strauss RG (Eds). Lippincott Williams and Wilkins. 2002

21. Carson JL, Armas B., Is There an Optimal Perioperative Hemoglobin? Evidence-Based Practice of Anesthesiology. Fleisher, LA, Saunders, Philadelphia. 2004: 197-204

22. Hennesey S, Carson JL, Ray W, Strom BL. Medicaid Data Bases. Pharmocoepidemiology - The Science of Post-Marketing Drug Surveillance, Strom BL (ed), Churchill Livingstone, Inc., New York, New York 2005

23. Ferreira G, Carson JL. Anemia and Transfusion Medicine. Just the Facts in Perioperative Medicine. Cohn SL, Smetana GW, Weed H.(Eds). McGraw-Hill, New York, New York 2006

24. Pfeifer,K, Carson JL. Anemia and Bleeding. Just the Facts in Perioperative Medicine. Cohn SL, Smetana GW, Weed H.(Eds). McGraw-Hill, New York, New York 2006

25. Hebert PC, Tinmouth A, Carson JL. Red cell transfuison in perioperative and critically ill patients. Blood Banking and Transfusion Medicine. Hillyer CD, Silberstein LE, Ness PM, Anderson KC, Roback JD (eds). Churchill Livingstone, Philadelphia, Pennsylvania, 2007

26. Carson JL, Hébert P. Anemia and Red Blood Cell Transfusion. Ross’s Principles of Transfusion Medicine. Simon TL, Snyder EL, Stowell CP, Strauss RG, Solheim BG, Petrides M. (Eds). AABB Press, Wiley Blackwell Publishing 2009

27. Carson JL, Armas B., Is There an Optimal Perioperative Hemoglobin? Evidence-Based Practice of Anesthesiology. Fleisher, LA, Saunders, Philadelphia. 2nd edition 2009:156-162

28. Carson JL, Adamson JW. Iron deficiency and heart disease: Ironclad evidence? Hematology 2010; American Society of Hematology Education Program Book. 348-350.

29. Sanders DW, Carson JL. Blood transfusion. Evidence-Based Orthopedics. Bhandari M lead editor. Wiley Blackwell Publishing Ltd, 2012

30. Kleinman S, Carson JL. Indications for red cell transfusion in the adult. In: UpToDate, Basow DS (Ed), UpToDate, Waltham, MA, 2012.

31. Carson JL, Patel, M., Is There an Optimal Perioperative Hemoglobin? Evidence-Based Practice of Anesthesiology. Fleisher, LA, Elsevier Saunders, Philadelphia. 2013:155-163.

32. Kuryian M, Carson JL. Allogeneic Blood Transfusion for Surgical andTraumatic Hemorrhage. In Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics. Kim HW, Greenbury AG (Eds), Springer Berlin 2013:117-126.

33. Carson JL, Kleinman S. Indications for red cell transfusion in the adult. In: UpToDate, Basow DS (Ed), UpToDate, Waltham, MA, 2012, 2013, 2014, 2015,2016.

34. Carson JL, Hébert P. Anemia and Red Blood Cell Transfusion. Ross’s Principles of Transfusion Medicine. Simon TL, McCullough J, Snyder EL, Solheim BG, Strauss RG. (Eds). Wiley Blackwell 2016:110-125.

35. Roubinian N, Carson JL. Rd blood cell transfusion strategies in adult and pediatric patients with malignancy. In: Transfusion Medicine. Hematology/Oncology Clinics of North America. Hendrickson JE, Tormey CA Editors, Canellos GP, Bunn HF Consulting Editors. 2016: 529-540.

 

C. Patents Held: N/A  

D. Other Articles (Reviews, Editorials, etc.) In Journals; Chapters; Books; other Professional Communications

106. Carson JL. Noncardiac Surgery in the Cardiac Patient. Book Review. Ann Intern Med l983, 99:580. 107. Carson JL. Difficult Diagnosis. Book Review. Ann Intern Med l985; 102:728-9 108. Carson JL, Strom BL: Techniques of post-marketing surveillance. An Overview. Medical Toxicology

14  

1986; 1: 237-46. 109. Carson, JL, Strom, BL. The gastrointestinal side effects of the nonsteroidal anti-inflammatory drugs.

Journal of Clinical Pharmacology 1988;28:554-559. 110. Carson JL, Elliot, DL. Care of the pregnant patient with medical illness. Journal of General Internal

Medicine 1988;3:577-88. 111. Strom BL, Taragin MI, Carson JL. Gastrointestinal bleeding from the nonsteroidal anti-inflammatory

drugs. Agents and Actions. 1990;29:27-38. 112. Taragin MI, Carson JL, Strom BL. Gastrointestinal side effects of nonsteroidal anti-inflammatory drugs.

Gastroenterology Digest 1991;6:15-16. 113. Strom BL, Carson JL. Use of automated databases for pharmacoepidemiological research. Epidemiologic

Review 1990;12:87-107. 114. Kelly MA, Carson JL, Palevsky HI, Schwartz JS. Diagnosing Pulmonary Embolism. (Letter) Annals of

Internal Medicine 1991;115:834. 115. Carson JL. Commentary on "Risk of serious gastrointestinal complications related to use of nonsteroidal

anti-inflammatory drugs. A meta-analysis." ACP J Club 1992 March-April: Ann Intern Med 1992;116:60. 116. Carson JL. Estimates of risk of posttransfusion hepatitis. (Letter) American Journal of Medicine

1992;93:357-8. 117. Carson JL, Kelley MA, Terrin ML. The clinical course of pulmonary embolism. (Letter) New England

Journal of Medicine 1992;327:957-8. 118. Carson JL. Commentary on "Impedance plethysmography or ultrasonography for deep-vein thrombosis.

ACP J Club 1993 March-April: Ann Intern Med 1993;118:50-1. 119. Carson JL, Willett LR. Is a hemoglobin of 10 g/dl required for surgery. Medical Clinics of North America

March 1993;77:335-47. 120. Carson JL, Willett LR. Toxicity of the Nonsteroidal Anti-Inflammatory Drugs: An Overview of the

epidemiological evidence. Drugs 1993;46:243-8. 121. Willett LR, Carson JL, Williams JW. Current diagnosis and management of sinusitis. Journal of General

Internal Medicine 1994;9:38-45. 122. Willett LR, Carson JL, Strom BL. Epidemiology of gastrointestinal damage associated with nonsteroidal

anti-inflammatory drugs. Drug Safety 1994;10:170-181. 123. Carson JL. Morbidity risk assessment in the surgically anemic patient. American Journal of Surgery

1995;170, Number 6A (Suppl): 32S-36S. 124. Strom BL, Berlin JA, Kinman JL, Hennessy S, Feldman H, Kimmel S, Carson JL. Risk of operative site

bleeding with parenteral Ketorolac. (Letter) JAMA 1996;276,5:372. 125. Manoukian AV, Carson JL. Nonsteroidal Anti-Inflammatory Drug-Induced Hepatic Disorders. Drug

Safety 1996;1:64-71. 126. Carson JL, Duff A, Noveck H, Poses RM, Berlin JA, Lawrence VA. Perioperative blood transfusion.

(Letter) JAMA 1998;279:1610. 127. Carson JL, Chen AY. In search of the transfusion trigger. Clinical Orthopedics and Related Research

1998;357:30-35. 128. Chen AY, Carson JL. Perioperative management of anemia. Br J Anesthesia 1998; 81(Suppl 1):20-24. 129. Carson JL. Transfusion therapy: Clinical Principles and Practice. Book Review. Transfusion 1999;

39:548. 130. Maltz GM, Siegel JE, Carson JL. Hematological management of GI bleeding. Gastroenterology Clinics

of North Amer 2000;29:169-187. 131. Ferreira G, Carson JL. Clinical prediction rules for the diagnosis of pulmonary embolism. American

Journal of Medicine 2002;113:337-338. 132. Carson JL. Should ICU patients receive erythropoietin? JAMA 2002;288:2884-6. 133. Carson JL, Hill S, Carless P, Hébert P, Henry D. Transfusion triggers: A Systematic review of the

literature. Transfusion Medicine Reviews 2002;16:187-199. 134. Hill SR, Carless PA, Henry DA, Carson JL, Hebert PC, McClelland DBL, Henderson KM. Transfusion

thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Systematic Reviews 2002;(2):CD002042

135. Willett LR, August DA, Carson JL. Breast cancer prevention. New options for patients and clinicians. N J Med 2002;99:27-34.

136. Armas-Loughran B, Kalra R, Carson JL. Evaluation and management of anemia and bleeding disorders in

15  

surgical patients. Med Clin North Am. 2003;87(1):229-242. 137. Ferreira GS, Carson JL. Diagnosis of venous thromboembolism: factors determining individual patient

probabilities of deep vein thrombosis or pulmonary embolism. Curr Hematol Rep 2003; 2(5):423-428. 138. Carson JL, Terrin ML, Magaziner J. Anemia and postoperative rehabilitation. Can J Anaesth. 2003;50(6

Suppl):S60-S64. 139. Freudenberger RS, Carson JL. Is there an optimal hemoglobin value in the cardiac intensive care unit?

Curr Opin Crit Car. 2003;9(5):356-361. 140. Carson JL, Berlin JA. Will we ever know if Leukoreduction of red blood cells should be performed?

Canadian Journal of Anesthesia, 2004;51: 407-411 141. Kuriyan M, Carson JL. Blood Transfusion Risks in the Intensive Care Unit. Blood Transfusion in the

Critically Ill, Critical Care Clinics 2004, (20): 237-253 142. Carson JL, Ferreira G. Transfusion triggers: how low can we go? Vox Sang. 2004;87 Suppl 2:218-221. 143. Carson JL. In search of the transfusion threshold. Hematology. 2005;10 Suppl 1:86-88. 144. Kuriyan M, Carson JL. Anemia and clinical outcomes. Anesthesiol.Clin.North America. 2005;23:315-25 145. Carson, JL. Subcutaneous unfractionated heparin vs low-molecular-weight heparin for treatment of acute

thromboembolism: Issues of efficacy and cost. JAMA 2006;296:991-993. 146. Carson JL, Terrin ML, Magaziner J, Chaitman BR, Apple FS, Heck DA, Sanders D. Transfusion Trigger

Trial for Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair (FOCUS). Transfusion 2006; 46(12):2192-2206.

147. Klein HG, Spahn DR, Carson JL. Red Cell Transfusion in Clinical Practice. Lancet 2007;370:415-426. 148. Corwin HL, Carson JL. Blood Transfusion: When is more really less? N Engl J Med 2007;356:1667-

1669. 149. Carson JL, Klein HG. Bad, bad blood. Critical Care Medicine. 2008; 36:2708-2709 150. Kumar A, Carson JL. Perioperative anemia in the elderly. Clin Geriatr Med 2008;24:641-8. 151. Carson JL, Kuriyan M. What should trigger a transfusion? Transfusion 2010;50:2073-2075. 152. Carless PA, Henry DA, Carson JL, Hebert PP, McClelland B, Ker K. Transfusion thresholds and other

strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2010; 10:CD002042.

153. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic Red blood cell transfusion. Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD002042.

154. Abrams JS, Owen WF, Jr., Brenner JC, Donlen J, Leone P, Carson JL, et al. Perspectives on humanism in medicine from the 2012 Edward J. III Excellence in Medicine honorees. MD advisor: a journal for the New Jersey medical community. 2012;5(2):4-9.

155. Blajchman, M A, Carson, JL, Eikelboom, JW, Heddle, NM. et al. The role of comparative effectiveness research in transfusion medicine clinical trials: proceedings of a National Heart, Lung, and Blood Institute workshop. Transfusion 2012;52:1363-78.

156. Carson JL, Grossman BJ, Kleinman, S, Tinmouth AT, et al. Red blood cell transfusion: A Clinical Practice Guideline from the AABB. Ann Intern Med 2012;157:49-58.

157. Hogshire LC, Patel MS, Rivera E, Carson JL. Evidence review: periprocedural use of blood products. J Hosp Med 2013;8:647-52.

158. Carson JL, Hebert PC. Here We Go Again—Blood Transfusion Kills Patients? JAMA-Internal Medicine 2013;173:139-140.

159. Carson JL, Strair R. Transfusion strategies in hematologic and nonhematologic disease. Hematology Am Soc Hematol Educ Program 2014;2014:548-52.

160. Carson JL, Hebert PC. Should we universally adopt a restrictive approach to blood transfusion? It's all about the number. The American journal of medicine 2014;127:103-4.

161. Carson JL, Patel MS. Red blood cell transfusion thresholds: can we go even lower? Transfusion 2014;54:2593-4.

162. Carson JL. Blood transfusion and risk of infection: new convincing evidence? JAMA : the journal of the American Medical Association 2014;311:1293-4.

163. Hebert PC, Carson JL. Transfusion threshold of 7 g per deciliter-The new normal. N Engl J Med 2014;371:1459-1461.

164. Carson, JL, Stanworth, SJ, Roubinian N, Fergusson, DA, Triulizi, D, Dorree, C, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Systematic Reviews (On line October 12, 2016)

16  

165. Tobian AA, Heddle NM, Wiegmann TL, Carson JL. Red blood cell transfusion: 2016 clinical practice guidelines from AABB. Transfusion. 2016;56(10):2627-30

E. Abstracts 1. Peer Reviewed Abstracts

 1. Schwartz JS, Kelly MA, Carson JL: "Predicting Pulmonary Embolus", Society for Medical Decision

Making (Abstract), October 1981. 2. Williams S, Schwartz J, Segal B, Soper K, Iskandrian A, Anderson G, Kotler M, Bloom B, Carson J:

"Optimal Strategies for Managing Suspected Coronary Artery Disease". Society for Medical Decision Making. (Abstract), October 1981.

3. Carson JL, Eisenberg JM, Shaw L, Spitz LK: Use of Receiver Operating Characteristic Curves to Compare Five Assays for Prostatic Acid Phosphatase. Clinical Research. (Abstract), May, 1982.

4. Cebul RD, Carson JL, Silber SA, Schwartz JS: Clinical Diagnosis of Suspected Deep Venous Thrombosis. Clinical Research. (Abstract), May 1982.

5. Carson JL, Eisenberg JM, Shaw L, Kundel H: Comparison of the Diagnostic Accuracy of Four Assays of Prostatic Acid Phosphatase: A Receiver Operating Characteristic Curve Analysis. Medical Decision Making (Abstract), October 1982.

6. Carson JL, Eisenberg JM, Shaw L, Kurdel HL, Soper K: Comparison of the Diagnostic Accuracy of Four Assays of Prostatic Acid Phosphatase: A Receiver Operating Characteristic Curve Analysis. Medical Decision Making (Abstract), October 1982.

7. Carson JL, Strom BL, Morse ML, Stolley PD, Soper KA, Jones JK: The Relative Gastrointestinal Toxicity of the Nonsteroidal Anti-Inflammatory Drugs. Clinical Research. (Abstract), May 1983.

8. Strom BL, Carson JL, Morse ML, West SL, Soper KA: Allergic and/or Anaphylactoid Reactions Associated with Zomepirac Sodium and Other Non-Steroidal Anti-Inflammatory Drugs. Clinical Research. (Abstract) 1985.

9. Strom BL, Carson JL, Shinnar R, Jones R, Morse ML: Relative Frequency of Upper Gastrointestinal Bleeding from Oral Potassium Chloride Preparations. Clinical Research. (Abstract) 1986; 385A.

10. Carson JL, Poses RM, Spence RK, Bonavita G: Anemia and Surgery: The Relationship Between the Severity of Anemia and Surgical Mortality and Morbidity. Clinical Research. (Abstract) 1987; 340A.

11. Carson JL, Strom BL, Schinnar R, Sim E: Do Corticosteroids Really Cause Upper GI Bleeding? Clinical Research. (Abstract) 1987; 340A.

12. Strom BL, West SL, Sim E, Carson, JL: The Epidemiology of Acute Flank Pain Syndrome from Suprofen: A Novel Use of the Spontaneous Reporting System. Clin Pharmacol Ther. (Abstract) l988; 144.

13. Carson JL, Strom BL, Schinnar R, Sim E, Maislin G. Drug Induced Neutropenia. J Clin Res Drug Dev 1988;2:179-206.

14. Strom BL, Carson JL, Schinnar R, Sim E, Maislin G, Morse ML. Drug-Induced Neutropenia. Clin Pharmacol Ther. (Abstract) 1989; 158.

15. Strom BL, Carson JL, Schinnar R, Sim E, Maislin G, Morse ML. Drug-Induced Neutropenia. European Journal of Clinical Pharmacology Vol. 36 Supp. 1989 Abstracts of IV World Conference on Clinical Pharmacology and Therapeutics. Marthime-Heidelberg July 23-28, 1989.

16. Strom BL, Carson JL, Halpern A, Schinnar R, Sim E, Maislin G, Stolley P, Tilson H, Joseph M, Dai W, Chen D, Stern R, Lundin F, Tomita D, Shaw M and Morse ML. Pharmacoepidemiology Studies of Stevens-Johnson Snyndrome: An Example of a Disease Presenting Problems for Class Identification. J. Clin. Res. Drug Dev. (Abstract) 1989; 226-27.

17. Taragin MI, Carson JL, Wilczek AP, Karns ME, Trout JR, Duff, AE. Medical Malpractice and Physician Error: The Influence of Physician Specialty and Demographic Variables. Clinical Research (Abstract) 1990;38,2:723A.

18. Taragin MI, Carson JL, Wilczek AP, Karns ME, Trout JR, Duff AE. Physician Demographics and the Risk of Medical Malpractice: The Feminine Advantage? Clinical Research (Abstract) 1990: 38,2;723A.

19. Carson JL, Strom BL, Duff AE, Gupta A, Das KM. Validation of the Diagnosis of Acute Hepatitis in

17  

Medicaid Data. J. Clin. Res. Pharmacoepidemiol. (Abstract) 1990;4:112-145. 20. Taragin MI, Carson JL, Strom BL. Gastrointestinal Side Effects of the Nonsteroidal Anti-Inflammatory

Drugs. Gastroenterology Digest (Abstract) 1990;8:269-280. 21. Tarigin MI, Carson JL, Holman J. Medical Malpractice and Patient Satisfaction. Clinical Research

(Abstract) 1991;39(2):631A. 22. Carson JL, Kelley ML, Terrin ML, Duff AE, et al. The Clinical Course of Pulmonary Embolism.

Clinical Research (Abstract) 1991;39(2):631A. 23. Carson JL, Strom BL, Duff A, Gupta A, Das KM. Acute Hepatitis from Sulfonamide and Erythromycin.

Clinical Research (Abstract) 1992;40(2):554A. 24. Carson JL, Duff A, Strom BL, Poses RM, Spence RK, Trout R, Winslow W. Anemia and Surgery: Effect

of Cardio-Pulmonary Disease on Mortality. Journal of General Internal Medicine (Abstract) 1995;10(4):40.

25. Sonnenberg FA, Carson JL, Nizam RA, Kosmin M, Yomtovian RA, Russell L. Relative costs of procurement of autologous and allogeneic blood: A study of blood banks at four institutions. Transfusion (Abstract) 1995;35 (supplement) 82S.

26. Feldman HI, Kinman JL, Berlin JA, Hennessey S, Kimmel SE, Farrar J, Carson J, Strom BL. Keterolac: The risk of Acute renal failure (ARF). Journal of Investigative Medicine (Abstract) 1997:280A.

27. Carson JL, Terrin ML, Barton F, Aaron R, Greenburg AG, Heck DA, Magaziner J, McClelland B. Keating J, Merlino F, Bunce G, Duff A, Noveck H. Surgical Blood Transfusion Trial: Pilot Study. Transfusion (Abstract) 1997;37 (Supplement) 38S.

28. Carson JL, Altman DG, Duff A, Noveck H, Weinstein MP, Sonnenberg FA, Hudson JI. Risk of Bacterial Infection from Allogeneic Blood Transfusion. Transfusion (Abstract) 1997;37 (Supplement) 74S

29. Lawrence VA, Hilsenbeck SG, Noveck H, Poses R, Strom B, Berlin J, Carson J. Medical complications after hip fracture repair. JGIM (Abstract) 1998;13 (Supplement) 23.

30. Lawrence VA, Hilsenbeck SG, Noveck H, Poses R, Strom B, Berlin J, Carson J. Cardiac and pulmonary complications after hip fracture repair. JGIM (Abstract) 1998;13 (Supplement) 23.

31. Carson JL, O’Hara D, Duff A, Poses RM, Berlin JA, Lawrence VA, Noveck H, Strom BL. The relationship between the type of anesthesia and postoperative mortality and morbidity. JGIM (Abstract) 1998;13 (Supplement) 24.

32. Carson JL, Duff A, Berlin JA, Lawrence VA, Poses RM, Noveck H, Strom BL. Does postoperative blood transfusion reduced the risk of myocardial infarction? JGIM (Abstract) 1998;13 (Supplement) 24.

33. Baumgarten M, Margolis D, Berlin J, Carson J. Racial Differences in pressure ulcer incidence among elderly surgical patients. Gerontologist (Abstract) 1998;38 (special issue 1):334.

34. Baumgarten M, Margolis D, Berlin J, Carson J. Racial differences in pressure ulcer incidence among elderly surgical patients. Annual Meeting of the Gerontological Society of America: Philadelphia 1998.

35. Baumgarten M, Margolis D. Carson J, Berlin J, Strom B, Garino J, Kagan S, Kavesh W. Iatrogenic factors and hospital-acquired pressure ulcers in elderly surgical patients. Journal of the American Geriatrics Society (Abstract) 1998;46:S75.

36. Sullivan-Marx E, Baumgarten M, Strumpf N, Evans L, Maislin G, Carson J. Discharge outcomes among restrained nursing home residents hospitalized with hip fracture. Journal of the American Geriatrics Society. (Abstract P177) 1999;47:S56.

37. Grimes JP, Noveck H, Gregory P, Butler M, Carson JL. The effect of time to surgery on mortality in hip fracture patients. Journal of General Internal Medicine. (Abstract) 2000;15 (Supplement) 119

38. Carson JL, Noveck H, Berlin JA. Mortality and morbidity in patients with very low blood counts who decline blood transfusion. Transfusion 2000 (Abstract) Supplement 9

39. Lawrence VA, Hilsenbeck SG, Noveck H, Poses RM, Carson JL. Medical complications after hip fracture repair. Journal of General Internal Medicine (Abstract) 2000; 15 (Supplement) 79

40. Greenberg JD, Sharma R, Noveck H, Bueno M, Carson JL Incidence of reimbursement denials and reversals by managed care organizations at a university hospital. Journal of General Internal Medicine (Abstract) 2002; 17 (Supplement) 195

41. Greenberg JD, Sharma R, Noveck H, Bueno M, Carson JL Variation of reimbursement denials and reversals among managed care organizations. Journal of General Internal Medicine (Abstract) 2002; 17 (Supplement) 186

42. Carson JL, Noveck H, Berlin JA. Mortality and morbidity in patients with very low blood counts who decline blood transfusion. Journal of General Internal Medicine (Abstract) 2002; 17 (Supplement) 111

18  

43. Bershad J, Motavalli, L, Noveck H, HooverD, Schneider S, Loftus A, Carson JL. Perioperative glucose levels are not associated with short-term mortality or morbidity in diabetic cardiac surgery patients. Journal of General Internal Medicine (Abstract) 2004; 19 (Supplement) 190

44. Steinberg MB, Greenhaus S, Schmelzer AC, Bover MT, Foulds J, Carson JL. Benefit of combination pharmacotherapy in a primary-care modelled randomized trial for medically-ill smokers. Journal of General Internal Medicine (Abstract) 2008; 23 (Supplement) 302

45. Vogel TR, Dombrovskiy VY, Carson JL, Haser PB, Lowery SF, Graham AM. Infectious Complications after Elective Open AAA Repair: Impact of Leapfrog Volume Criteria, Hospital Characteristics, and Patient Demographics. J Vasc Surg 2009; 49: 5S (Abstract)

46. Vogel TR, Dombrovskiy VY, Carson JL, Haser PB, Graham AM. Lower extremity angioplasty: Impact of practitioner specialty and volume on practice patterns and healthcare resource utilization J Vasc Surg (abstract) 2009;49, Issue 5, Supplement, S1

47. Carson JL, Terrin ML, Magaziner J, Chaitman, B, Sanders D Impact of Transfusion Triggers on Postoperative Myocardial Infarction or Death, Circulation 2009;120:2155

48. Carson JL, Terrin ML, Magaziner J, Sanders D, Cook DR, Hildebrand K. Transfusion Trigger Trial for Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair (FOCUS): The Principal Results. ASH Annual Meeting Abstracts 2009;114:LBA-6-.

49. Carson JL. Transfusion Triggers : State of the Art in 2010. Acta Anaesth Belg. 2010; 61: 14 50. Carson JL, Sieber F, Hoover DR, Noveck, H, etal. A Randomized Clinical Trial of Liberal Versus

Restrictive Transfusion Strategy Evaluating Long Term Survival and Cause of Death: Results from the FOCUS Trial. Blood 2014 124:757

  

PRESENTATIONS: A. Scientific (Basic Science): B. Professional (Clinical):

2000 Transfusion Mortality and Morbidity in Orthopedic Surgery. Network for Advancement of Transfusion Alternatives (NATA) First Annual Meeting, Barcelona, Spain

2000 Controversies in Internal Medicine and Diagnostic Testing and Biostatistics. American College of Physicians New Jersey Internal Medicine Board Review Course. Sayreville, NJ

2001 Transfusion Triggers: Systematic Review and Meta-Analysis. Second Annual NATA Symposium, Berlin, Germany

2001 Transfusion Triggers: Where’s the Beef? AABB Annual Meeting, Washington, DC 2001 Controversies in Internal Medicine and Diagnostic Testing and Biostatistics. American College of

Physicians New Jersey Internal Medicine Board Review Course. Sayreville, NJ 2002 What is Pharmacoepidemiology? Pharmacovigilance: ADR Monitoring in Europe & the USA, London 2002 Alternatives to Blood Transfusion Jehovah’s Witness Patients. AABB Oxygen Therapeutics &

Alternative Therapies Conference, Arlington, VA 2002 Controversies in Internal Medicine and Diagnostic Testing and Biostatistics. American College of

Physicians New Jersey Internal Medicine Board Review Course. Sayreville, NJ 2002 Variation of Reimbursement Denials and Reversals Among Managed Care Organizations and Mortality

and Morbidity in Patients with Very Low Postoperative Hemoglobin Levels Who Decline Blood Transfusion. SGIM Annual Meeting, Atlanta, GA

2002 Strategies for handling a potentially diminished blood supply. BBTS Annual Conference, Edinburgh, UK 2002 Critical Hematocrits. Royal College of Physicians, London 2002 Allogeneic Blood Transfusion Leukodepletion: Where and When? European Society of

Anaesthesiologists Anniversary Meeting, France 2003 Risk of Anemia & Transfusion Triggers: Implications for the Care of the Bloodless Patient. Jersey Shore

Medical Center, Neptune, NJ 2003 Limits of Bloodless Surgery. Blood Transfusion Alternatives Symposium at the Asia Pacific International

Society of Blood Transfusion Conference in New Delhi, India 2003 Impact of HB Concentration on Morbidity. NATA Meeting San Francisco, CA 2003 Evidence-based Transfusion Practices. International Association for Biologicals, NIH, Bethesda, MD 2003 Controversies in Internal Medicine. ACP New Jersey Internal Medicine Board Review Course. Raritan

19  

Bay Medical Center, Old Bridge, NJ 2003 What’s wrong with British Blood & Critical Haematocrits? BBTS The Sensible Use of Blood

Conference, London, UK 2004 Transfusion Triggers: How Low Can You Go? International Society of Blood Transfusion in Edinburgh,

UK 2004 Controversies in Internal Medicine and Diagnostic Testing and Biostatistics. American College of

Physicians New Jersey Internal Medicine Board Review Course. Sayreville, NJ 2004 The Role of EPO in the Perioperative Preparation of the Anemic Patient. Society for Advancement of

Blood Management, Cape Cod, MA 2005 Early Massive Trauma Transfusion: Current State of the Art. USAISR Transfusion Symposium, San

Antonio, TX 2005 Controversies in Internal Medicine and Diagnostic Testing and Biostatistics. American College of

Physicians New Jersey Internal Medicine Board Review Course. Sayreville, NJ 2006 In Search of the Transfusion Trigger. ISH Meeting, Istanbul, Turkey 2006 Blood Transfusion & Impact on Outcomes in Elderly. Preventive Medicine & Community Health,

Medical Grand Rounds, Mountainside Hospital, Montclair, NJ 2006 Blood Transfusion-Cardiovascular Disease in Patients. NATA, Malaga Spain 2006 Cardiovascular Disease in Patients. University of Pennsylvania, Cardiology Update, Philadelphia, PA 2006 FOCUS NIH Study. Canadian Orthopedic Association Meeting, Toronto, Canada 2006 Controversies in Internal Medicine and Diagnostic Testing and Biostatistics. American College of

Physicians New Jersey Internal Medicine Board Review Course. Sayreville, NJ 2007 Risks of Anemia & Benefits of Red Blood Cell Transfusion in Critically Ill Patients: What do we really

know? Society of Critical Care Meeting, San Antonio, TX 2007 Erythopoiesis Stimulating Agents and Anemia Management: Safety Concerns. Society of Critical Care

Meeting, Washington, DC 2007 Controversies in Internal Medicine and Diagnostic Testing and Biostatistics. American College of

Physicians New Jersey Internal Medicine Board Review Course. Sayreville, NJ 2007 In Search of the Transfusion Trigger. Grand Rounds at Lahey Clinic, Massachusetts 2007 In Search of the Transfusion Trigger. Grand Rounds at St. Peter’s University Hospital, New Brunswick,

NJ 2007 In Search of the Transfusion Trigger. Grand Rounds at Cooper University Hospital, Camden, NJ 2007 Risk of Anemia and the Transfusion Trigger. Perioperative Medicine Summit, Cleveland Clinic, OH 2007 When to Transfuse or When not to Transfuse, That is the Question! Society for the Advancement of

Blood Management Annual Meeting, Wisconsin 2007 Bloodless Surgery. UMDNJ-RWJMS, OBGYN and Reproductive Sciences Grand Rounds, New

Brunswick, NJ 2008 In Search of the Transfusion Trigger. Maimonides Medical Center Grand Rounds, Brooklyn, NY 2008 In Search of the Transfusion Trigger. Medical Grand Rounds, St. Louis University, MO 2008 Controversies in Transfusion Medicine. The Society of Hospital Medicine Annual Meeting, San Diego,

CA 2008 Hemoglobin Based Oxygen Carriers: Current Status and Future Directions. Alternative Focused

Clinical Design Conference sponsored by the FDA and NIH. Bethesda, MD 2008 GIM Research. Visiting Professor lecture at University of Michigan, Ann Arbor, MI 2008 Age of Blood: What’s the Evidence? Advisory Committee on Blood Safety & Availability. Rockville,

MD 2008 Controversies in Internal Medicine and Diagnostic Testing and Biostatistics. American College of

Physicians New Jersey Internal Medicine Board Review Course. Sayreville, NJ 2008 Effective and Safe Management of Anemia: Erythropoiesis Stimulating Agents and Anemia Management:

Safety Considerations. Center for Bio-Medical Communication, Inc., Critical Care Medicine Course, Hackensack, NJ

2008 Hemoglobin Based Oxygen Carriers. Department of Health & Human Services, HBOC Workshop, NIH Campus, Bethesda, MD

2008 Evaluation of a New Treatment: Is it Better, Worse, or Just as Good? A Clinician’s Perspective.

20  

Transfusion Medicine Hemostasis Network Annual Investigators Meeting. 2008 Introduction to Bloodless Medicine and the Treatment of the Bloodless Medicine Patient. RWJUH Center

for Nursing Education and Research Provider Unit, New Brunswick, NJ 2009 In Search of the Transfusion Threshold. Visiting Professor Lecture at Peking Union Medical College,

Beijing, China 2009 In Search of the Transfusion Threshold. Beijing Blood Center, Beijing, China 2009 Anemia in Coronary Artery Disease Patients. NATA Meeting, Austria 2009 Challenges in Performing Clinical Research: How I tried to Determine the Transfusion Trigger. Jersey

Shore Medical Center Research Day, Neptune, NJ 2009 Controversies in Internal Medicine and Diagnostic Testing and Biostatistics. American College of

Physicians New Jersey Internal Medicine Board Review Course. Sayreville, NJ 2009 Report from the Surgery Committee: State of the Science Symposium in Transfusion Medicine and

Hemostasis. National Heart, Lung and Blood Institute, Bethesda, MD 2009 FOCUS: Preliminary Results. American Association of Blood Banks Annual Meeting, New Orleans, LA 2009 Impact of Transfusion Triggers on Postoperative Myocardial Infarction. American Heart Association

Scientific Sessions, Orlando, FL 2009 Transfusion Trigger Trial for Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip

Fracture Repair (FOCUS): The Principle Results. American Society of Hematology Annual Meeting, New Orleans, LA

2010 In Search of the Transfusion Trigger. Cardiology Grand Rounds, Montefiore Medical Center, NY, NY 2010 In Search of the Transfusion Trigger. University of California, San Francisco 2010 In Search of the Transfusion Trigger. Brigham & Women’s Hospital, Boston, MA 2010 In Search of the Transfusion Trigger. Rhode Island Hospital, Providence, RI 2010 In Search of the Transfusion Trigger. Robert Wood Johnson Medical School, Surgical Grand Rounds,

New Brunswick, NJ 2010 Transfusion Trigger Trial in Coronary Heart Disease. Robert Wood Johnson Medical School,

Cardiology Grand Rounds, New Brunswick, NJ 2010 FOCUS: Preliminary Results. NATA Annual Meeting, Barcelona, Spain 2010 In Search of the Transfusion Trigger. Calgary Hospital Grand Rounds, Calgary, Canada 2010 Study Design and Evaluation of the Evidence. ASFA Annual Meeting, New Orleans, LA 2010 Controversies in Internal Medicine and Diagnostic Testing and Biostatistics. American College of

Physicians New Jersey Internal Medicine Board Review Course. Sayreville, NJ 2010 MINT Trial Presentation. Montefiore Medical Center, Moses Division, Bronx, NY 2010 MINT Trial Presentation. Montefiore Medical Center, Weiler Division, Bronx, NY 2010 MINT Trial Presentation. University of Pittsburgh Medical Center, Pittsburgh, PA 2010 In Search of the Transfusion Trigger. Hackensack University Medical Center, Hackensack, NJ 2010 In Search of the Transfusion Trigger. 7th Annual Innovations & Trends in Cardiovascular Care, New

Brunswick, NJ 2010 Systematic Review of Transfusion Thresholds. American Association of Blood Banks Annual Meeting,

Baltimore, MD 2010 Blood Transfusion in the Critical Care Unit. Critical Care Symposium, CentraState Medical Center,

Trenton, NJ 2010 In Search of the Transfusion Trigger. Annual Meeting, Society for Anesthesia & Resuscitation,

Oostende, Belgium. 2010 Iron Deficiency & Congestive Heart Failure: Ironclad Evidence? American Society of Hematology

Annual Meeting, Orlando, FL 2011 Transfusion Triggers and Erythropoietin Stimulating Agents. Centers for Medicare & Medicaid Services,

Baltimore, MD 2011 In Search of the Transfusion Trigger. Medical Grand Rounds, University Medical Center at Princeton,

Princeton, NJ 2011 In Search of the Transfusion Trigger. Seminar at Western Galilee Hospital, Israel 2011 Transfusion Triggers in Orthopedic Surgery. 12th Annual NATA Symposium, Ireland 2011 In Search of the Transfusion Trigger. California Blood Bank Society Annual Meeting, Las Vegas, NV 2011 In Search of the Transfusion Trigger. Royal Columbia Hospital, University of Alberta, Canada 2011 Controversies in Internal Medicine and Diagnostic Testing and Biostatistics. American College of

21  

Physicians New Jersey Internal Medicine Board Review Course. Sayreville, NJ 2011 In Search of the Transfusion Trigger. Robert Wood Johnson Medical School, Urology Grand Rounds,

New Brunswick, NJ 2011 The Role of Pilot Studies in Planning Large Clinical Trials. NHLBI Comparative Effectiveness Research

Meeting, Bethesda, MD 2012 Blood Transfusions and Outcomes: A Case-based Approach. American College of Physicians NJ

Chapter Meeting, South Iselin, NJ 2012 Management of Preoperative Anemia and Transfusion Triggers: Where Do We Stand? NATA Annual

Symposium, Copenhagen 2012 In Search of the Transfusion Trigger: How Low Can You Go? 6th Annual Margo S. Kruskall

Lectureship, Dana Farber Cancer Institute, Boston, MA 2012 Red Cell Guidelines/FOCUS Study. America’s Blood Centers Medical Directors Workshop, Buffalo, NY 2012 Providing the Evidence for Patient Blood Management. The Future of Blood Transfusion, Royal College

of Pathologists, London, UK. 2012 RBC Transfusion Triggers: How Low Can You Go? Combined Critical Care/Anesthesia and Surgery

Grand Rounds, John Hopkins University Baltimore, MD 2012 RBC Transfusion Triggers: How Low Can You Go? Beth Israel Medical Center Grand Rounds, New

York, NY 2012 Diagnostic Testing and Biostatistics. New Jersey American College of Physicians Internal Medicine

Board Review, Woodbridge NJ 2012 RBC Transfusion Triggers: How Low Can You Go? AABB Annual Meeting, Boston, MA 2012 RBC Transfusion Guidelines and RBC Transfusion Clinical Trials. AABB Annual Meeting, Boston, MA 2012 Transfusion Thresholds in patients with Cardiovascular Disease: How Low Can You Go? University of

Pennsylvania Cardiology Update. Atlantic City, NJ 2012 Blood Management: RBC Transfusion Triggers. Leiden University, The Netherlands 2012 RBC Transfusion Triggers: How Low Can You Go? Chinese Society Blood Transfusion, Guangzhou,

China 2013 Transfusion Triggers: How Low Can You Go? NJABBP, Scientific Keynote Speaker, The Science and

Art of Transfusion Medicine, New Brunswick, NJ 2013 Transfusion Strategies, An Evidence-Based Update. Susquehanna Health Critical Care Symposium,

Williamsport Regional Medical Center, Williamsport, PA 2013 Diagnostic Testing and Biostatistics. New Jersey American College of Physicians Internal Medicine

Board Review, Woodbridge NJ 2013 RBC Transfusion Threshold: How Low Can We Go? RWJMS Orthopedic Surgery Grand Rounds, New

Brunswick, NJ 2013 The Ideal Hemoglobin Trigger for Transfusion: What is the Evidence? Society of Thoracic Surgery, Los

Angeles, CA 2013 Perioperative MI. Cardiology Research Presentation, Rutgers RWJMS, New Brunswick, NJ 2013 The Evidence Base for Red Blood Cell Transfusions. ISBT 23rd Regional Congress, Amsterdam,

Netherlands 2013 Developing a Research Project. Medicine, Intern Research Retreat, Rutgers RJWMS, New Brunswick,

NJ 2013 RBC Transfusion Thresholds: How Low Can You Go? Georgetown University Medical Grand Rounds,

Washington, DC 2013 RBC Transfusion Thresholds: How Low Can You Go? St. Barnabas Medical Grand Rounds, Livingston,

NJ 2013 RBC Transfusion Thresholds: How Low Can You Go? Blue Cross/Blue Shield Cardiovascular

Consortium, Grand Rapids, MI 2013 Blood Utilization in China. REDS III Meeting, Mianyang, China 2013 Treatment Thresholds in Medical & Surgical Patients. Blood Management Symposium, St. Michael’s

Hospital, Toronto, Canada 2013 Introduction: Inclusion of Research Ethics throughout Research Partnership, Inaugural Research

Education Series, Rutgers, Robert Wood Johnson Medical School. 2013 Approach to Research Questions. Anesthesia Grand Rounds, Rutgers RWJMS, New Brunswick, NJ 2014 Red Blood Cell Transfusions: How Low Can you Go? Pathology Grand Rounds, University of

22  

Pennsylvania, Philadelphia, PA. 2014 RBC Transfusion Thresholds: How Low Can You Go? Medicine Grand Rounds, Washington University

School of Medicine, St. Louis, MO 2014 Red Blood Cell Transfusions: How Low Can You Go? Anesthesia Grand Rounds, Massachusetts General

Hospital, Boston, MA 2014 Age of Blood: Does it Matter? 15th Annual NATA Symposium on Patient Blood Management,

Hemostasis and Thrombosis, Portugal, Spain 2014 Transfusion Thresholds for Patients with Coronary Artery Disease. 15th Annual NATA Symposium on

Patient Blood Management, Hemostasis and Thrombosis, Portugal, Spain 2014 Red Cell Transfusion Thresholds: How Low Can We Go? Medicine, Rutgers, New Jersey Medical

School, Newark, NJ 2014 Improving Clinical Practice Through the Use of Clinical Practice Guidelines, 33rd International Congress

of the ISBT, Seoul, Korea 2014 In Search of the Transfusion Threshold, New York Hospital/Cornell University, Division of Hematology

& Oncology, New York, NY 2014 Red Blood Cell Transfusion Thresholds, How Low Can we Go, Annual Symposium of the German

Society for Transfusion Medicine, Dresden, Germany 2014 In Search of the Transfusion Threshold, New York Hospital/Cornell University, Division of Hematology

& Oncology, New York, NY 2014 Can you use observational data to assess impact of transfusion methodology - DEBATE ‘No way, of

course not, are you kidding?’, Australian New Zealand Society for Blood Transfusion, Perth, Australia 2014 Developing transfusion guidelines’, Australian New Zealand Society for Blood Transfusion, Perth,

Australia 2014 Transfusion triggers: ‘More or less blood’, Australian New Zealand Society for Blood Transfusion,

Perth, Australia 2014 Red Blood Cell Transfusion Thresholds, How Low Can we Go, Grifols Transfusion Medicine Symposium,

Austin, TX 2014 Red Blood Cell Transfusion Thresholds, How Low Can we Go, West China Hospital, Department of

Anesthesia, Chengdu, China 2014 Red Blood Cell Transfusion Thresholds, How Low Can we Go, Chinese Ministry of Health Transfusion

Training, Chengdu, China 2014 Blood Utilization in China, REDS III Meeting, Wuhan, China 2014 Transfusion Strategies in Hematologic and Non-Hematologic Disease. Annual American Society of

Hematology Meeting, San Francisco 2014 Long Term Survival and Cause of Death. Annual American Society of Hematology Meeting, San

Francisco 2015 AABB Red Blood Cell Guidelines: Why, How and Impact on Clinical Practice, Japan Transfusion

Medicine Conference, IPC, Kamukara, Japan 2015 AABB Red Blood Cell Guidelines: Why, How and Impact on Clinical Practice, Japan Transfusion

Medicine Conference, Osaka Red Cross, Japan 2015 Red Blood Cell Transfusions: How Low Can you Go, Kaiser Anesthesia Symposium, Anaheim, CA 2015 Red Cell Transfusion Overview. National Heart, Lung and Blood Institute, Bethesda, MD 2015 Transfusion-Related Immunomodulation: Yes, but What Does It Do to Our patients?, 16th Annual NATA

Symposium, Prague. 2015 Long-Term Mortality in the Transfusion Trigger Trial for Functional Outcomes in Cardiovascular Patients

Undergoing Surgical Hip Fracture Repair (FOCUS), 16th Annual NATA Symposium, Prague. 2015 Clinical Research Course: RBC transfusion thresholds: How Low Can You Go?, Department of

Anesthesiology, West China Hospital, Sichuan University, Chengdu, China 2015 Clinical Research Course: What everyone should know about clinical trials, Department of Anesthesiology

West China Hospital, Sichuan University, Chengdu, China 2015 Clinical Research Course: Designing a clinical trial on transfusion thresholds, Department of

Anesthesiology , West China Hospital, Sichuan University, Chengdu, China 2015 ACP Board Review: Diagnostic Testing and Biostatistics, Wyndham Hamilton Park Hotel and Conference

23  

Center, Florham Park, NJ 2015 The use of Octaplex and Fresh Frozen Plasma to Prevent Bleeding in Patients Undergoing Radiographic

and Bedside Procedures, Octapharma, Inc., Hoboken, NJ 2015 RBC Transfusion Thresholds: The Restrictive Transfusion Perspective, SABM Annual Meeting, Orlando,

FL 2015 Pediatric Transfusion Guidelines: Developing Transfusion Guidelines, Washington University, Austin, TX 2015 Strengths and Weaknesses of Clinical Trials, AABB National Meeting, Anaheim, CA 2015 The use of Octaplex and Fresh Frozen Plasma to Prevent Bleeding in Patients Undergoing Radiographic

and Bedside Procedures, Octopharma, Hoboken NJ, 2015 Strengths and Weaknesses of Clinical Trials, AABB National Meeting, Anaheim, CA 2015 Update of RBC Transfusion Utilization study, REDS III Meeting, Chongqing, China 2015 In Search of the Transfusion Trigger, How Low Can We Go?,Medical Grand Rounds, Rutgers, Robert

Wood Johnson Medical School. 2016 Which transfusion strategy is best in cardiac patients? Societe Francaise de Cardiologie, Paris, France 2016 RBC Transfusion in Patients with Cardiovascular Disease: Higher Thresholds? Cardiology Grand

Rounds, Rutgers, Robert Wood Johnson Medical School. 2016 Does Plasma Reduce Bleeding in Patients Undergoing Invasive Procedures, Radiology Grand Rounds,

Rutgers, Robert Wood Johnson Medical School 2016 A Pragmatic Randomized Trial Comparing Spinal versus General Anesthesia for Hip Fracture Surgery:

REGAIN, Orthopedics Grand Rounds, Rutgers, Robert Wood Johnson Medical School 2016 Transfusion Thresholds- 2016 Cochrane Review, NATA Annual Meeting, Dublin, Ireland 2016 Restrictive RBC Transfusion Strategy-But How Low? NATA Annual Meeting, Dublin, Ireland 2016 RBC Transfusion Strategy: Now What? NATA Annual Meeting, Dublin, Ireland 2016 Blood Transfusion in Anemic Cardiac Patients: How Low can We Go?, Washington State Hospital

Association, Seattle, WA 2016 Life of clinical investigator: N of 1 study. National Blood Foundation. National AABB Annual Meeting 2016 Clinical Practice Guidelines from the AABB: Red Blood Cell Transfusion Thresholds. National AABB

Annual Meeting 2016 Red Blood Cell Transfusion: how low can we go? Surgical Grand Rounds. Rutgers, Robert Wood Johnson

Medical School 2017 Transfusion Thresholds in Cardiac Patients: how low can we go? Cardiology Grand Rounds. Rutgers,

Robert Wood Johnson Medical School 2017 Clinical Practice Guidelines from the AABB: Red Blood Cell Transfusion Thresholds and Storage. NATA

Annual Symposium, Florence, Italy 2017 What trigger for RBC transfusion after control of massive bleeding? 18th Annual NATA Symposium,

Florence, Italy 2017 How to implement PBM in real life-what can we learn from the masters: Discussant. 18th Annual NATA

Symposium, Florence, Italy 2017 Red Blood Cells-what now and what are the next steps? Patient Blood Management Symposium,

Montreal, Quebec 2017 Myocardia Ischemia and Transfusion Trial. Grand Rounds. Staten Island University Hospital, Staten

Island, NY 2017 Red Blood Cell Transfusion in Cardiac Patients: how low can we go? Cardiology Grand Rounds.

University of North Carolina-Chapel Hill, Chapel Hill, NC 2017 Red Blood Cell Transfusion in Cardiac Patients: how low can we go? Cardiology Grand Rounds.

Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY 2017 Red Blood Cell Transfusion in Patients with Cardiovascular Disease: how low can you go? Cardiology

Cardiovascular Symposium. Williamsburg, Virginia 2017 Red Blood Cell Transfusion in Patients with Cardiovascular Disease: how low can you go? Cardiology

Grand Rounds. CHI St. Luke’s Health, Houston, TX 2017 Transfusion Thresholds and Patient Reported Outcomes. National AABB Annual Meeting, San Diego,

California 2017 Transfusion Thresholds in Cardiac Patients: how low can we go? Grand Rounds. University of Toledo

Medical Center. Toledo, Ohio 2017 Transfusion Thresholdsin Cardiac Patients: how low can we go? Grand Rounds. Thomas Jefferson

24  

University Hospital, Philadelphia, Pennsylvania